Ruffer LLP Royalty Pharma PLC Transaction History
Ruffer LLP
- $1.93 Billion
- Q2 2025
A detailed history of Ruffer LLP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ruffer LLP holds 177,931 shares of RPRX stock, worth $6.52 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
177,931Holding current value
$6.52 Million% of portfolio
0.33%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
486Shares Held
282MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.5 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.34 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$844 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$491 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$446 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...